Skip to content

Medical emergency? What to do

Breast cancer vaccine may prevent recurrence

3-RXPublished November 22, 20052 min read

Key points

  • A vaccine using a protein that is a biological "marker" for breast cancer, called HER2/neu, prompts a specific immune response and may prevent recurrence of the disease in certain patients who have become disease-free after treatment for breast cancer, according to researchers.
  • In the Journal of Clinical Oncology, Peoples of Walter Reed Army Medical Center, Washington, DC and colleagues explain that E75 is a part of the HER2/neu protein that is seen in many breast cancers.
  • Vaccinated patients showed an expansion of white blood cells that specifically attacked E75 and destroyed breast tumor cells that expressed HER2/neu.
  • Peoples pointed out that the "reduction in recurrences in our vaccinated breast cancer patients is similar to the recent reports using Herceptin -- trastuzumab -- a monoclonal antibody, that targets the same HER2/neu protein as our vaccine."

A vaccine using a protein that is a biological "marker" for breast cancer, called HER2/neu, prompts a specific immune response and may prevent recurrence of the disease in certain patients who have become disease-free after treatment for breast cancer, according to researchers.

"While our results are preliminary," lead investigator Dr. George E. Peoples told Reuters Health, "we are encouraged that this type of trial, evaluating cancer prevention as opposed to cancer treatment, will ultimately reveal the power, and appropriate future use, of cancer vaccines."

In the Journal of Clinical Oncology, Peoples of Walter Reed Army Medical Center, Washington, DC and colleagues explain that E75 is a part of the HER2/neu protein that is seen in many breast cancers. "Our clinical trials are investigating E75 mixed with (a cell growth factor) as a simple vaccine strategy," the researchers explain.

The team administered the vaccine to 24 patients with lymph node-positive breast cancer, while 29 lymph node-positive breast cancer patients acted as a comparison group.

Vaccinated patients showed an expansion of white blood cells that specifically attacked E75 and destroyed breast tumor cells that expressed HER2/neu.

At 22 months follow-up, the only two deaths that had occurred were in women in the comparison. Disease-free survival was 85.7 percent in the vaccinated group and 59.8 percent in comparison group. Corresponding recurrence rates were 8 percent and 21 percent.

Peoples pointed out that the "reduction in recurrences in our vaccinated breast cancer patients is similar to the recent reports using Herceptin -- trastuzumab -- a monoclonal antibody, that targets the same HER2/neu protein as our vaccine."

He added: "Preclinical data suggest that the two may be synergistic, and, therefore, the combination of Herceptin and our vaccine may be even more effective in preventing recurrences in high-risk breast cancer patients."

In an accompanying editorial, Drs. Lupe G. Salazar and Mary L. Disis of the University of Washington, Seattle, call the study data "provocative," but note that it remains to be determined which patients might benefit most from vaccination.

SOURCE: Journal of Clinical Oncology, October 20, 2005.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underBreast Cancer
Cancer

Strong social ties benefit breast cancer patients

Breast cancer patients who have a strong social support system in the first year after diagnosis are less likely to die or have a recurrence of cancer, according to new research from Vanderbilt-Ingram Cancer Center…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.